$Valneva (VALN.US)$Valneva Submits Label Extension Application For Its Chikungunya Vaccine, IXCHIQ, To The U.S. FDA To Potentially Include Adolescents And Antibody Persistence Up To 2-Years
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more